Biotech Values

[Mufaso]

If VKTX hope you are right WRT to VK2809 top line results this week in NASH. While you are correct that it is 4-5 weeks after last follow-up, this is a very small company (21 people as of 12/31/22) and I suspect they have been very busy with starting the phase 2 trial on VK2735 plus they just started the ORAL trial on VK2735.

I think June is more likely for results. For maximum impact, they could time the release to be around EASL June 21-24.

I'm holding through this event as well because:
- risk is reduced by VK2735 phase 1 results and they have 400+ mill in cash.
- large short position will amplify good results which I think are likely.